Sort by

Date

Institutional score

Impact

Patients

List order

Sort

Categories

Studies

111 Unclassified

100 Case Reports

96 Reviews

93 Research

28 Advanced Trials

23 Early Trials

22 Other Trials

1 Meta-Analysis

Guidelines

2 Guidelines

1 Consensuses

Congresses

38 Abstracts

1

Research

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

Tian Erming, Zhan Fenghuang, Walker Ronald, Rasmussen Erik, Ma Yupo ...

The New England journal of medicine Vol 349(26)

Read

Date 25 Dec 2003

Institutional score
13.47
Impact
1998.19

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 25 Dec 2003

Institutional score
13.47
Impact
1998.19
2

Research

Magnetic resonance imaging of the spine in multiple myeloma.

Ludwig H, Frühwald F, Tscholakoff D, Rasoul S, Neuhold A ...

Lancet (London, England) Vol 2(8555)

Read

Date 15 Aug 1987

Institutional score
0.00
Impact
999.09

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 15 Aug 1987

Institutional score
0.00
Impact
999.09
3

Research

Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone.

Knowling M A, Harwood A R, Bergsagel D E

Journal of clinical oncology : official journal of the American Societ... Vol 1(4)

Read

Date 01 Apr 1983

Institutional score
0.00
Impact
541.88

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 01 Apr 1983

Institutional score
0.00
Impact
541.88
4

Research

Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease.

Dallas S L, Garrett I R, Oyajobi B O, Dallas M R, Boyce B F ...

Blood Vol 93(5)

Read

Date 01 Mar 1999

Institutional score
16.10
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 01 Mar 1999

Institutional score
16.10
Impact
144.67
5

Research

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.

Croucher P I, Shipman C M, Lippitt J, Perry M, Asosingh K ...

Blood Vol 98(13)

Read

Date 15 Dec 2001

Institutional score
391.47
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 15 Dec 2001

Institutional score
391.47
Impact
144.67
6

Research

Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma.

Abe Masahiro, Hiura Kenji, Wilde Javier, Moriyama Keiji, Hashimoto Toshihiro ...

Blood Vol 100(6)

Read

Date 15 Sep 2002

Institutional score
12.87
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 15 Sep 2002

Institutional score
12.87
Impact
144.67
7

Research

Development of an in vivo model of human multiple myeloma bone disease.

Alsina M, Boyce B, Devlin R D, Anderson J L, Craig F ...

Blood Vol 87(4)

Read

Date 15 Feb 1996

Institutional score
0.00
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 15 Feb 1996

Institutional score
0.00
Impact
144.67
8

Research

Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft mode...

Gunn W Grady, Krause Ulf, Lee Narae, Gregory Carl A

Blood Vol 117(5)

Read

Date 03 Feb 2011

Institutional score
14.64
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 03 Feb 2011

Institutional score
14.64
Impact
144.67
9

Research

Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease.

Oyajobi Babatunde O, Franchin Giovanni, Williams Paul J, Pulkrabek Donna, Gupta Anjana ...

Blood Vol 102(1)

Read

Date 01 Jul 2003

Institutional score
16.10
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 01 Jul 2003

Institutional score
16.10
Impact
144.67
10

Research

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease.

Dairaghi Daniel J, Oyajobi Babatunde O, Gupta Anjana, McCluskey Brandon, Miao Shichang ...

Blood Vol 120(7)

Read

Date 16 Aug 2012

Institutional score
0.00
Impact
144.67

Add to library

Add to library

Select a folder

Create a new folder +

Cancel

Date 16 Aug 2012

Institutional score
0.00
Impact
144.67

View

per page

Page

1

2

3

4

5

6

7

8

9

10

Last